Mohammed Azman – CEO, PERKESO, Malaysia
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Address: Level 6, Quill 9,
112, Jalan Semangat,
46300 Petaling Jaya,
Selangor, Malaysia.
Tel: +603 7495 2600
Web: http://gsk.com.my/
GlaxoSmithKline (GSK) is one of the world’s leaders in pharmaceutical research and development with a combination of skills and resources that provide a platform for delivering strong growth in today’s rapidly changing healthcare environment. GSK’s mission is to improve the quality of human life by enabling people to do more, feel better and live longer. With a firm foundation in science, GSK discover, develop, manufacture and distribute vaccines, prescription medicines and consumer healthcare products. Headquartered in the UK, with major business operations in the US, GSK employs more than 100,000 people in 117 countries.
In Malaysia, GSK has established a strong presence for almost 50 years. It employs close to 600 employees and has an annual sales turnover of over USD100Million.
GSK’s pharmaceutical products cover a broad spectrum of vaccines and major therapeutic areas such as anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic and oncology.
GSK is a leader in the important area of vaccines and are developing new treatments for cancer. GSK pharmaceuticals business serves more than 130 countries. The vaccines are used for immunizing children, and prevent flu and hepatitis. Every day, more than 3 million doses of GSK’s vaccines are distributed around the world.
GSK has a large portfolio of products, ranging from tablets and toothpaste to inhalers and complex capsules, in over 28,000 different pack sizes and presentations. More than 34,000 people work in GSK’s Global Manufacturing & Supply (GMS) to make and distribute these products easily and effectively to millions of people around the world. They work in 80 manufacturing sites in 37 countries.
In Malaysia, GSK wide product range covers healthcare from vaccines and over-the counter(OTC) medicines to nutritional health drink, oral care and pharmaceuticals.
Dato’ Sri Dr Mohammed Azman, CEO at PERKESO, the Malaysian Social Security Organization, explains PERKESO’s main areas of focus as well as the current health burdens the organization is looking…
Jennifer Lopez, executive director of the British Malaysian Chamber of Commerce, discusses foreign investment trends in Malaysia and how the chamber is serving its members, especially UK companies operating in…
Lim Teng Chyuan, president of the Malaysian Association for Pharmaceutical Suppliers (MAPS), discusses the association’s role in solving and supporting its members with the numerous regulatory issues and compliance requirements…
Amrahi Buang, president of the Malaysian Pharmaceutical Society details the ‘lack’ of recognition and integration of pharmacists in Malaysia. He also explains the complex dual healthcare system and the governmental…
The managing director of Boston Consulting Group Malaysia discusses the gap between public and private healthcare in the country, and what can be done to bridge it. What appears…
Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region…
Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable quality healthcare in a country that is naturally diverse as…
Klaus Boehncke and Yennie Tan from PwC Malaysia discuss the factors that will make the country a hub for medical tourism and the importance of listening to patient demands at…
Dr. Hassan, founder and CEO of Healwell and House of Healin, brings research and entrepreneurship together with the aim of turning Malaysian traditions into scientific innovation. Could you share…
Alan Ong, executive vice president for the Asia/Pacific region at INC Research, outlines the key challenges and opportunities that CROs face in the Malaysian clinical trial segment and describes INC’s…
Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in…
Sanofi’s general manager for Malaysia, Singpoare and Brunei discusses the benefits of implementing of a new channel business model and proudly showcases the dengue vaccine, 20 years after the company initiated…
See our Cookie Privacy Policy Here